As the global economy recovers in 2021 and the supply of the industrial chain improves, the Human Milk Oligosaccharides (HMO) market will undergo major changes. The latest research shows that the Human Milk Oligosaccharides (HMO) industry market size will be million US dollars in 2021, and will grow to million US dollars in 2028, with an average annual growth rate of %.

The global Human Milk Oligosaccharides (HMO) industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Human Milk Oligosaccharides (HMO) market during the next few years. The global Human Milk Oligosaccharides (HMO) market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Human Milk Oligosaccharides (HMO) market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom

Types list
2'-FL & 3-FL
Sialyllactose
LNT & LNnT

Application list
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others